Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.

Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.

Human (Hu) monoclonal antibodies (MAbs) against the human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) are useful tools in the structural and functional analysis of Env, are under development both as potential prophylaxis and as therapy for established HIV-1 infection, and have...

Bibliografiset tiedot
Päätekijät:	Sheppard, N, Davies, S, Jeffs, SA, Vieira, S, Sattentau, Q
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2007

Samankaltaisia teoksia

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.
Tekijä: Pruzina, S, et al.
Julkaistu: (2011)

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci
Tekijä: Pruzina, S, et al.
Julkaistu: (2011)

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
Tekijä: Moore, J, et al.
Julkaistu: (1994)

Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.
Tekijä: Shotton, C, et al.
Julkaistu: (1995)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.
Tekijä: Poignard, P, et al.
Julkaistu: (1996)

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
Tekijä: Sattentau, Q, et al.
Julkaistu: (1991)

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.
Tekijä: Kwong, P, et al.
Julkaistu: (2000)

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
Tekijä: Sattentau, Q, et al.
Julkaistu: (1993)

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.
Tekijä: Moore, J, et al.
Julkaistu: (1992)

Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.
Tekijä: Donatien Kamdem Toukam, et al.
Julkaistu: (2012-01-01)

PRODUCTION OF MONOCLONAL ANTIBODY AGAINST HUMAN IMMUNOGLOBULIN
Tekijä: J. Majidi, et al.
Julkaistu: (2000-04-01)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
Tekijä: Parren, P, et al.
Julkaistu: (1997)

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
Tekijä: Barton F. Haynes, et al.
Julkaistu: (2010-02-01)

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
Tekijä: Parren, P, et al.
Julkaistu: (1997)

Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins.
Tekijä: Gerald V Quinnan, et al.
Julkaistu: (2013-01-01)

Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
Tekijä: Moore, J, et al.
Julkaistu: (1993)

Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function.
Tekijä: Ruan, C, et al.
Julkaistu: (1981)

The role of the envelope glycoproteins in HIV-1 transmission and pathogenesis
Tekijä: Sattentau, Q
Julkaistu: (1996)

Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies.
Tekijä: Mcmichael, A, et al.
Julkaistu: (1981)

Development and characterisation of human monoclonal antibodies against the Ebola virus glycoprotein
Tekijä: Mendelsohn, S
Julkaistu: (2014)

Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1.
Tekijä: Jeffs, SA, et al.
Julkaistu: (2004)

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.
Tekijä: Delphine C Malherbe, et al.
Julkaistu: (2013-01-01)

Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
Tekijä: Kristen C Witt, et al.
Julkaistu: (2017-01-01)

Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.
Tekijä: Kong, L, et al.
Julkaistu: (2010)

Expression-System-Dependent Modulation of HIV-1 Envelope Glycoprotein Antigenicity and Immunogenicity
Tekijä: Kong, L, et al.
Julkaistu: (2010)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design (vol 57, pg 105, 1997)
Tekijä: Parren, P, et al.
Julkaistu: (1997)

Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies
Tekijä: Louie, Raymond H. Y., et al.
Julkaistu: (2018)

Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies.
Tekijä: Michael D Raleigh, et al.
Julkaistu: (2021-01-01)

Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
Tekijä: Fan Jun, et al.
Julkaistu: (2012-07-01)

Correction: Antigenic Properties of the Human Immunodeficiency Virus Envelope Glycoprotein Gp120 on Virions Bound to Target Cells.
Tekijä: PLOS Pathogens Staff
Julkaistu: (2015-06-01)

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
Tekijä: Healey, D, et al.
Julkaistu: (1990)

Physiologically‐based pharmacokinetic modeling of immunoglobulin and antibody coadministration in patients with primary human immunodeficiency
Tekijä: Sara N. Salerno, et al.
Julkaistu: (2022-10-01)

HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
Tekijä: Martin Zydek, et al.
Julkaistu: (2014-03-01)

High throughput optimization of protein-A affinity chromatography for capture of humanized monoclonal antibody
Tekijä: Pakiman, Norazrina
Julkaistu: (2012)

Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies.
Tekijä: J Peterson, et al.
Julkaistu: (1992-08-01)

DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.
Tekijä: Karolin Hijazi, et al.
Julkaistu: (2011-01-01)

Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.
Tekijä: Lindsay Crickard, et al.
Julkaistu: (2012-01-01)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
Tekijä: Medina-Ramírez, M, et al.
Julkaistu: (2017)

Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
Tekijä: Piñon, J, et al.
Julkaistu: (2003)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B.
Tekijä: Miwa Okamoto, et al.
Julkaistu: (2023-01-01)